3 new studies, with caveats, add to evidence Omicron is less severe than other COVID-19 variants
Thee separate studies out of England, Scotland, and South Africa on Wednesday suggested the new Omicron coronavirus is less likely to send people to the hospital and usually produces milder symptoms. The Omicron variant is also infecting more people at a much faster rate, among other caveats, so "this is a qualified good-news story," said Jim McMenamin, national COVID-19 incident director at Public Health Scotland and a co-author of the Scottish study.
"Cautious optimism is perhaps the best way to look at" these new studies, Manuel Ascano Jr., a virus researcher at Vanderbilt University, tells The Associated Press. "It is clearly good news, to a degree," said Neil Ferguson, who led the English research team at Imperial College London.
In South Africa, where the sharp surge in Omicron cases appears to have peaked and started to decline after a month, researchers found that people infected with Omicron had a roughly 70 percent lower risk of hospitalization versus other variants. The Scottish study, from a team at University of Edinburgh, found Omicron patients were two-thirds less likely to be hospitalized than Delta patients.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Imperial College researchers found that those infected with Omicron were 15 to 20 percent less likely to go to the emergency room and 40 percent less likely to be hospitalized overnight. Their analysis also found that Omicron's mutations made it intrinsically milder than Delta, BBC News reports. But Omicron hospitalizations are also believed to be stalling because majorities of the populations under study have some immunity from vaccines or previous infections.
The Imperial College team estimated that people with no prior immunity were only about 11 percent less likely to visit the ER with Omicron than Delta. The Scottish study found the odds of being reinfected are 10 times higher with Omicron than Delta, but that vaccines still provide some protection against symptomatic infection, especially if you got a third dose. Given the vigorous transmissibility of Omicron, hospitals are still expected to become overwhelmed, but mostly with unvaccinated people.
"If you are unvaccinated and you have never been infected, it is a little less severe than Delta," William Hanage, an epidemiologist at the Harvard T.H. Chan School of Public Health, tells The New York Times. "But that's a bit like saying you're being hit over the head with one hammer instead of two hammers. And the hammers are more likely to hit you now."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Ukraine hints at end to 'hot war' with Russia in 2025
Talking Points Could the new year see an end to the worst European violence of the 21st Century?
By Rafi Schwartz, The Week US Published
-
What does the FDIC do?
In the Spotlight Deposit insurance builds confidence in the banking system
By Joel Mathis, The Week US Published
-
2024: The year of conspiracy theories
IN THE SPOTLIGHT Global strife and domestic electoral tensions made this year a bonanza for outlandish worldviews and self-justifying explanations
By Rafi Schwartz, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published